Pages that link to "Q40604964"
Jump to navigation
Jump to search
The following pages link to Engineering sialic acid synthetic ability into insect cells: identifying metabolic bottlenecks and devising strategies to overcome them (Q40604964):
Displaying 27 items.
- Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins (Q24313398) (← links)
- Identification of the sequence encoding N-acetylneuraminate-9-phosphate phosphatase (Q24338722) (← links)
- Impact of cultivation conditions on N-glycosylation of influenza virus a hemagglutinin produced in MDCK cell culture. (Q34538848) (← links)
- Development of delivery methods for carbohydrate-based drugs: controlled release of biologically-active short chain fatty acid-hexosamine analogs (Q34573505) (← links)
- Peracetylated N-acetylmannosamine, a synthetic sugar molecule, efficiently rescues muscle phenotype and biochemical defects in mouse model of sialic acid-deficient myopathy (Q35710052) (← links)
- Comparing N-glycan processing in mammalian cell lines to native and engineered lepidopteran insect cell lines (Q35932897) (← links)
- Physiologic and pathophysiologic consequences of altered sialylation and glycosylation on ion channel function (Q35981911) (← links)
- Innovative use of a bacterial enzyme involved in sialic acid degradation to initiate sialic acid biosynthesis in glycoengineered insect cells (Q36392872) (← links)
- Extracellular and intracellular esterase processing of SCFA-hexosamine analogs: implications for metabolic glycoengineering and drug delivery. (Q36488687) (← links)
- Sialic acid metabolism and sialyltransferases: natural functions and applications (Q36501918) (← links)
- Protein N-glycosylation in the baculovirus-insect cell expression system and engineering of insect cells to produce "mammalianized" recombinant glycoproteins. (Q36601827) (← links)
- Isolation and analysis of a baculovirus vector that supports recombinant glycoprotein sialylation by SfSWT-1 cells cultured in serum-free medium (Q36730542) (← links)
- Metabolic glycoengineering: sialic acid and beyond (Q37405391) (← links)
- Metabolic oligosaccharide engineering: implications for selectin-mediated adhesion and leukocyte extravasation. (Q37950862) (← links)
- Metabolic glycoengineering bacteria for therapeutic, recombinant protein, and metabolite production applications (Q38452524) (← links)
- Glycoengineering of Esterase Activity through Metabolic Flux-Based Modulation of Sialic Acid. (Q38715644) (← links)
- Glycoengineering of Chinese hamster ovary cells for enhanced erythropoietin N-glycan branching and sialylation (Q38987190) (← links)
- Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example (Q39031683) (← links)
- Sialylation potentials of the silkworm, Bombyx mori; B. mori possesses an active α2,6-sialyltransferase (Q40608129) (← links)
- Applying Acylated Fucose Analogues to Metabolic Glycoengineering (Q41704611) (← links)
- Characterization of the metabolic flux and apoptotic effects of O-hydroxyl- and N-acyl-modified N-acetylmannosamine analogs in Jurkat cells. (Q44765733) (← links)
- DmSAS is required for sialic acid biosynthesis in cultured Drosophila third instar larvae CNS neurons (Q47072414) (← links)
- Experimental Design Considerations for In Vitro Non-Natural Glycan Display via Metabolic Oligosaccharide Engineering. (Q47172587) (← links)
- Exploiting biological complexity for strain improvement through systems biology (Q51602863) (← links)
- Improving Immunotherapy Through Glycodesign (Q59132146) (← links)
- Cell Line-, Protein-, and Sialoglycosite-Specific Control of Flux-Based Sialylation in Human Breast Cells: Implications for Cancer Progression (Q89967350) (← links)
- Exploiting metabolic glycoengineering to advance healthcare (Q91503235) (← links)